Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...

Mass spectrometry, a powerful tool for studying tiny molecules, has long helped scientists unlock secrets hidden in plants, ...

Researchers led by Université de Montréal pathology and cell-biology professor Marc Therrien have identified major structural ...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide ...

Terns Pharmaceuticals, Inc. ("Terns” or the "Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing ...

SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

National Institute of Health (NIH) scientists report that a first-in-human clinical trial of a new therapy based on the plant ...

The oral TKI sevabertinib has been granted priority review for use in patients harboring HER2 mutations in non-small cell ...

In recent years, overweight and obesity have become a serious global health problem, posing significant risk factors for ...

One provision stands out: the law’s “pill penalty.” The IRA doesn’t treat all medicines equally. “Small molecule” medicines, ...

The RNA Targeting Small Molecule Drug Discovery Market is poised for growth, driven by demand for treatments targeting cancer ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.